Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Clinical Study to Evaluate the Efficacy and Safety of Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression

NCT05361330 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05361330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Clinical Study to Evaluate the Efficacy and Safety of Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Completed
Start date
May 19, 2022
Completion date
May 29, 2024
Enrollment
160 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

outpatients / inpatients with depression